Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The wound healing cascade is enhanced through targeted delivery of key growth factors to modulate cellular processes, accelerate tissue repair and regeneration. Key growth factors involved are EGF, PDGF, FGF, VEGF, TGF-β, GM-CSF, and CTGF. Advanced drug delivery systems, such as micro/nanoparticles and hydrogels, are used to achieve controlled spatial-temporal release at the wound site. This approach is particularly effective in treating chronic wounds where natural repair mechanisms are compromised. Impaired expression or function of these growth factors can result in delayed or pathological wound healing states.
Binding to cell surface receptors, triggering intracellular signaling cascades, regulating gene expression related to migration, proliferation, differentiation, angiogenesis, and matrix synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound Healing Cascade Enhancement via Growth Factor Delivery (N/A).